Sep 16, 2021 | All News, INCA
INCA is proud to share that The Cost of Neuroendocrine Tumor Patient Healthcare: Comparison between Advanced Economies and Emerging and Developing Economies was selected for presentation at the 2021 ASCO Quality Care Symposium (September 24-25, 2021) which will be... 
Sep 13, 2021 | Access to Optimal Care, All News
Neuroendocrine tumor treatment Lutetium 177 Dota therapy is now available in more than 15 hospitals in India in all major cities like Delhi, Mumbai, Chandigarh, Lucknow, Pune, Kolkata, Chennai, Hyderabad and others. Advanced alpha therapy is also available at few... 
Sep 6, 2021 | All News, Awareness and Information
Sugandha Dureja, MD, FEBNM, nuclear medicine expert and founder of CNETS India, was the featured guest for the Carcinoid Cancer Foundation’s Luncheon with the Experts Facebook Live program on August 12, 2021. Dr. Dureja is among the first Indian specialists with... 
Sep 3, 2021 | All News, Research and Clinical Trials
CNETS is committed to improving the quality of life and survival for neuroendocrine (NET) cancer patients across Canada and in support of this vision introduced a new Research Funding Framework in 2016. The NET Cancer Research Grants provide grant-in-aid for NET... 
Sep 1, 2021 | All News, Awareness and Information
This month NeuroEndocrine Cancer Australia joined forces with 13 other cancer organizations across Australia, to create one unified voice in the New Normal, Same Cancer campaign, to encourage Australians with unexplained symptoms to #GetChecked. In this powerful... 
Aug 25, 2021 | All News, INCA
The European Cancer Summit is an annual event during which the European Cancer Organisation (E.C.O.) brings together leading oncology experts, experienced patient advocates, key opinion leaders, policy makers and politicians to discuss key issues in reducing the...
